StockData
Cytosorbents Corp logo

Cytosorbents Corp (CTSO) stock

CTSONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 2/30
$4.52−0.33 (-6.80%)

Close on Nov 17, 2026Market cap $284.05MP/E –Yield –

Cytosorbents operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Cytosorbents's operating cash flow for the twelve months ending Jun 30, 2026 was -$9.15M. For fiscal 2025 it was -$12.38M. The highest annual figure on record is -$2.48M in fiscal 2010.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$12.38M–
FY2024Dec 31, 2024-$14.43M–
FY2023Dec 31, 2023-$21.66M–
FY2022Dec 31, 2022-$28.23M–
FY2021Dec 31, 2021-$14.01M–
FY2020Dec 31, 2020-$5.61M–
FY2019Dec 31, 2019-$16.76M–
FY2018Dec 31, 2018-$10.84M–
FY2017Dec 31, 2017-$6.46M–
FY2016Dec 31, 2016-$6.73M–
FY2015Dec 31, 2015-$9.05M–
FY2014Dec 31, 2014-$6.28M–
FY2013Dec 31, 2013-$3.49M–
FY2012Dec 31, 2012-$3.62M–
FY2011Dec 31, 2011-$3.83M–
FY2010Dec 31, 2010-$2.48M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$583.00K–
Q1 FY2026Mar 31, 2026-$1.16M–
Q4 FY2025Dec 31, 2025-$4.83M–
Q3 FY2025Sep 30, 2025-$2.58M–
Q2 FY2025Jun 30, 2025-$1.51M–
Q1 FY2025Mar 31, 2025-$3.47M–
Q4 FY2024Dec 31, 2024-$2.34M–
Q3 FY2024Sep 30, 2024-$2.46M–
Q2 FY2024Jun 30, 2024-$4.79M–
Q1 FY2024Mar 31, 2024-$4.83M–
Q4 FY2023Dec 31, 2023-$6.41M–
Q3 FY2023Sep 30, 2023-$5.21M–
Q2 FY2023Jun 30, 2023-$6.93M–
Q1 FY2023Mar 31, 2023-$3.11M–
Q4 FY2022Dec 31, 2022-$5.34M–
Q3 FY2022Sep 30, 2022-$6.73M–
Q2 FY2022Jun 30, 2022-$8.04M–
Q1 FY2022Mar 31, 2022-$8.12M–
Q4 FY2021Dec 31, 2021-$5.49M–
Q3 FY2021Sep 30, 2021-$4.13M–
Q2 FY2021Jun 30, 2021-$2.04M-205.1%
Q1 FY2021Mar 31, 2021-$2.34M–
Q4 FY2020Dec 31, 2020-$1.06M–
Q3 FY2020Sep 30, 2020-$3.28M–
Q2 FY2020Jun 30, 2020$1.94M–
Q1 FY2020Mar 31, 2020-$3.21M–
Q4 FY2019Dec 31, 2019-$4.12M–
Q3 FY2019Sep 30, 2019-$5.21M–
Q2 FY2019Jun 30, 2019-$3.19M–
Q1 FY2019Mar 31, 2019-$4.24M–
Q4 FY2018Dec 31, 2018-$2.71M–
Q3 FY2018Sep 30, 2018-$2.64M–
Q2 FY2018Jun 30, 2018-$3.29M–
Q1 FY2018Mar 31, 2018-$2.20M–
Q4 FY2017Dec 31, 2017-$409.48K–
Q3 FY2017Sep 30, 2017-$2.18M–
Q2 FY2017Jun 30, 2017-$1.88M–
Q1 FY2017Mar 31, 2017-$1.98M–
Q4 FY2016Dec 31, 2016-$1.08M–
Q3 FY2016Sep 30, 2016-$2.47M–

More Cytosorbents figures

See a number that looks wrong?